Alseres Pharmaceuticals Stock (OTC: ALSE)

Latest news for Alseres Pharmaceuticals (OTC:ALSE) Stock

Alseres Pharmaceuticals Inc is a US-based biotechnology company. It is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system. The company's lead product candidate is Altropane, a proprietary molecular imaging agent which is used to diagnose Parkinson's disease and dementia. Further, it is focused on entering into partnerships to ensure development and commercialization of its product. Geographically the firm carries out its business through the region of United States.

ALSERES PHARMS INC by Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals Inc

ALSET CAP ACQUISITION CORP CL A

ALSET CAP ACQUISITION CORP RT

ALSET CAP ACQUISITION CORP UNIT 1 CL A & 1/2 WT EXP RED & 1 RT

ALSET CAP ACQUISITION CORP WT EXP RED

Alsea SAB de CV

ALSET AI VENTURES INC by ALSET AI VENTURES INC

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Alseres Pharmaceuticals

News

Latest news for Alseres Pharmaceuticals (OTC:ALSE) Stock